Patents Assigned to INTERNATIONAL INSTITUTE OF IMMUNOLOGY, INC.
  • Cancer antigen eEF2
    Patent number: 10265389
    Abstract: The present invention provides a method for detecting cancer using a protein expressed in various cancers, and a pharmaceutical composition for the treatment or prevention of such cancer using the protein as an indicator. Furthermore, the present invention provides a pharmaceutical composition containing a cancer antigen peptide derived from the protein. More particularly, the method comprises the step of determining the presence or amount of an eEF2 polypeptide or an eEF2 antibody in a sample obtained from a subject.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: April 23, 2019
    Assignee: INTERNATIONAL INSTITUTE OF IMMUNOLOGY, INC.
    Inventors: Haruo Sugiyama, Yusuke Oji